Encompass Health Corporation EHC
Nov 5, 2026, 12:57 PM EST
- YTD
- +33.07%
- 1 year
- +22.50%
- Market cap
- 13.86B
- Revenue (ttm)
- 6.34B
- Profit margin
- 10.17%
- EPS (ttm)
- 6.25
- Shares out
- 98.30M
- P/E ratio
- 22.60
- Forward P/E
- 20.48
- Dividend
- 0.84 (0.61%)
- Ex-dividend date
- Jan 3, 2027
- YTD return
- +33.07%
- 1-year return
- +22.50%
- Volume
- 689.94K
- Avg volume
- 1.01M
- Open
- 143.14
- Previous close
- 141.03
- Day's range
- 140.55 – 143.36
- 52-week range
- 92.77 – 143.36
- Beta
- 0.67
- Analysts
- Strong Buy
- Price target
- 156.08 (+10.5%)
- Earnings date
- Feb 4, 2027
2Y +39.72 (+39.19%)
Key statistics
- Enterprise value
- 16.86B
- PEG ratio
- 0.41
- Price / sales
- 2.19
- Price / book
- 5.17
- Dividend yield
- 0.62%
- Payout ratio
- 12.48%
- Revenue growth
- 8.90%
- Free cash flow
- 266.90M
- Total cash
- 76.20M
- Total debt
- 2.80B
- Return on equity
- 25.11%
- Short % of float
- 3.80%
- 50-day average
- 123.46
- 200-day average
- 110.39
Analyst view
Consensus: strong buy
- Target (low)
- 142.00
- Target (mean)
- 156.08
- Target (high)
- 177.00
- Strong buy1
- Buy12
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 1.61.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 1.60 | — | — | — |
| Oct 28, 2026 | Sep 30, 2026 | 1.36 | 1.52 | +0.16 | +11.76% |
| Aug 5, 2026 | Jun 30, 2026 | 1.48 | 1.55 | +0.07 | +4.73% |
| Apr 30, 2026 | Mar 31, 2026 | 1.51 | 1.60 | +0.09 | +5.96% |
| Feb 5, 2026 | Dec 31, 2025 | 1.29 | 1.46 | +0.17 | +13.18% |
| Oct 29, 2025 | Sep 30, 2025 | 1.19 | 1.23 | +0.04 | +3.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | main | Buy | Buy |
| Oct 30, 2026 | TD Cowen | main | Buy | Buy |
| Oct 30, 2026 | Truist Securities | reit | Buy | Buy |
| Oct 30, 2026 | Keybanc | main | Overweight | Overweight |
| Oct 29, 2026 | Barclays | main | Overweight | Overweight |
| Aug 10, 2026 | TD Cowen | main | Buy | Buy |
About Encompass Health Corporation
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- encompasshealth.com
News
Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know 
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run? 
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $150 
Truist Securities Reiterates Buy on Encompass Health, Raises Price Target to $156 
Here's Why Encompass Health (EHC) is a Strong Value Stock 
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $150 
Encompass Health Q3 Earnings Call Highlights 
Encompass Health Corporation (EHC) Q3 2026 Earnings Call Transcript 
Encompass Health Q3 2026 Earnings Call Transcript 
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $151
Your note
Sign in to keep a note on EHC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHARBONNEAU ELISSA JOY | Officer | Stock Award(Grant) | Feb 18, 2026 | 22,756 |
| COLTHARP DOUGLAS EDWARD | Chief Financial Officer | Sale | Aug 9, 2026 | 241,368 |
| DARBY JOHN PATRICK | General Counsel | Sale | Aug 30, 2026 | 75,041 |
| FAY EDMUND M | Officer and Treasurer | Stock Gift | Mar 8, 2026 | 86,325 |
| HERMAN JOAN E | Director | Stock Award(Grant) | Oct 14, 2026 | 49,724 |
| KATZ LESLYE G | Director | Stock Award(Grant) | Oct 14, 2026 | 49,724 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.63% | 10,484,385 | 1.48B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.12% | 5,055,801 | 713.27M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.99% | 4,924,664 | 694.77M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.54% | 4,475,896 | 631.46M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.32% | 3,278,739 | 462.56M | Jun 29, 2026 |
| State Street Corporation | 3.23% | 3,185,798 | 449.45M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 3,514,046 | 495.76M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 3,150,844 | 444.52M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.38% | 2,347,546 | 331.19M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.31% | 2,275,892 | 321.08M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.46% | 1,441,139 | 203.32M | Jun 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Large Cap Core Trust | 1.29% | 1,274,147 | 179.76M | Jun 29, 2026 |